Korro Bio (KRRO) Profit After Tax (2018 - 2026)

Korro Bio (KRRO) has 9 years of Profit After Tax data on file, last reported at -$19.8 million in Q1 2026.

• Quarterly Profit After Tax rose 15.2% year-over-year to -$19.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$113.7 million (down 29.23% YoY) and the FY2025 annual result came in at -$117.3 million, down 40.36% from the prior year.
• Profit After Tax advanced to -$19.8 million in Q1 2026, from -$50.0 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $6.2 million in Q4 2022 to a low of -$50.0 million in Q4 2025.
• A 5-year average of -$21.2 million and a median of -$21.0 million in 2024 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2022 — Profit After Tax surged 128.77% — and 2023, when it slumped 511.11%.
• Tracing KRRO's Profit After Tax over 5 years: stood at $6.2 million in 2022, then tumbled by 511.11% to -$25.4 million in 2023, then climbed by 14.38% to -$21.8 million in 2024, then sank by 129.84% to -$50.0 million in 2025, then jumped by 60.37% to -$19.8 million in 2026.
• The last three Profit After Tax figures came in at -$19.8 million (Q1 2026), -$50.0 million (Q4 2025), and -$18.1 million (Q3 2025), per Business Quant data.